PCNXL2-CDCA7 Fusion FISH Probe
The PCNXL2-CDCA7 Fusion FISH Probe is used to confirm a fusion of the PCNXL2 and CDCA7 genes. The fusion of the PCNXL2 and CDCA7 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| PCNXL2-CDCA7-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-RERE | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-REOR | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-REGO | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-REGR | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-OROR | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-GORE | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-GROR | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| PCNXL2-CDCA7-20-AQAQ | 20 (40 μL) | 200 μL |
|
CDCA7 Gene Summary
This gene was identified as a c-Myc responsive gene, and behaves as a direct c-Myc target gene. Overexpression of this gene is found to enhance the transformation of lymphoblastoid cells, and it complements a transformation-defective Myc Box II mutant, suggesting its involvement in c-Myc-mediated cell transformation. Two alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
Gene Name: Cell Division Cycle Associated 7
Chromosome: CHR2: 174219560 -174233718
Locus: 2q31.1
Gene Diseases
The PCNXL2 CDCA7 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|